13F

Stock

Acadia Pharmaceuticals Inc

ACAD · held by 12 managers

Reported value

$56.3M

Holders

12

+0 new · −0 exited

Holders’ est. mark

−$110.4K

Price effect on 5 books still in the name

Largest holder

$25.4M

MORGAN STANLEY

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
MORGAN STANLEY1.19M$25.4MHeld
BANK OF AMERICA CORP /DE/887.8K$18.9MHeld
BARCLAYS PLC435K$9.28M−$98.3KAdded$62K
Hudson Bay Capital Management LP70.3K$1.5MHeld
VIRTUS ADVISERS, LLC43K$917.1K−$9.88KCut−$9.88K
OP Asset Management Ltd6.42K$137K−$1.48KCut−$707.2K
Leonteq Securities AG3.61K$77K−$541Added$26.3K
Essential Partners LLC1.31K$28K−$132Added$15.6K
IFP Advisors, Inc1.1K$23.6KHeld
Allworth Financial LP589$12.6KHeld
Kilter Group LLC58$1.24KHeld
KBC Group NV3.62K$77Held

Positions as of Q3 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.